参考文献/References:
[1] Ingold JA, Reed GB, Kaplan HS,et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med, 1965, 93:200-208.
[2] Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma:the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys, 2006, 65(2):426-434.
[3] 申文江,王绿化.放射治疗损伤.北京:中国医药科技出版社,2001.128-133.
[4] Reed GB Jr, Cox AJ Jr. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol, 1966, 48(4):597-611.
[5] 彭瑞云,壬德文,杨德彪.等.放射性肝纤维化过程的定量研究.军事医学科学院院刊,1996,10(1):36-38.
[6] Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology, 1980, 79(6):1178-1191.
[7] 孙世良.放射性肝炎.国外医学放射医学分册,1979,3(3):169-171.
[8] Lawrence TS, Ten-Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys, 1992, 23(4):781-788.
[9] Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria:version 2.0. an improved reference for grading the acute effects of cancer treatment:impact on radiotherapy. Int J Radiat Oncol Biol Phys, 2000, 47(1):13-47.
[10] 曾昭冲.腹盆部肿瘤放射治疗学.上海:复旦大学出版社,2007:36-37.
[11] Johnson PM, Grossman FM, Atkins HL. Radiation induced hepatic injury; its detection by scintillation scanning. Am J Roentgenol Radium Ther Nucl Med, 1967, 99(2):453-462.
[12] Jeffrey RB Jr, Moss AA, Quivey JM, et al. CT of radiation-induced hepatic injury. A JR Am J Roentgenol, 1980, 135(3):445-448.
[13] Ahmadi T, hai Y, Onaya H, et al. CT evaluation of hepatic injury hollowing proton beam irradiation:appearance, enhancement, and 3D size reduction pattern. J Comput Assist Tomugr, 1999, 23(5):655-663.
[14] 伍少鹏,陈彬璞.局限性放射性肝损伤的CT诊断.中国医学影像技术,2002,18(12):1277-1278.
[15] Yamasaki SA, Marn CS, Francis IR, et al, High-dose localized radiation therapy for treatment of hepatic malignant tumors:CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol, 1995, 165(1):79-84.
[16] Stiskal M, Demsar F, Mtihler A, et al. Contrast-enhanced MR imaging of two superparamagnetic RES-eontrast agents:functional assessment of experimental radiation-induced liver injury. J Magn Reson Imaging, 1999, 10(1):52-56.
[17] Unger EC, Lee JK, Weyman PJ. CT and MR imaging of radiation hepatitis. J Comput Assist Tomogr, 1987, 11(2):264-268.
[18] Onaya H, Itai Y, Yoshioka It, et al. Changes in the liver parenchyma after proton beam radiotherapy:evaluation with MR imaging. Magn Resort Imaging, 2000, 18(6):707-714.
[19] Kawamoto S, Soyer PA, Fishman EK, et al. Nonneoplastic liver disease:evaluation with CT and MR imaging. Radiographics, 1998, 18(4):827-848.
[20] Yankelevitz DF, Knapp PH, Henschke CI, et al. MR appearance of radiation hepatitis. Clin Imaging, 1992, 16(2):89-92.
[21] Garra BS, Shawker TH, Chang R, et al. The ultrasound appearance of radiation-induced hepatic injury. Correlation with computed tomography and magnetic resonance imaging. J Ultrasound Med, 1988, 7(11):605-609.
[22] Dawson LA, Normolle D, Baher JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys, 2002, 53(4):810-821.
[23] Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol, 2005, 15(4):279-283.
[24] Minsky BD, Leibel SA. The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole. Cancer Treat Rev, 1989, 16(4):213-219.
[25] Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int.1 Radiat Oncol Biol Phys, 1991, 21(1):109-122.
[26] 国家核安全局.辐射确定性效应(HAZl900).北京:围家核安全局.1990:2-32.
[27] 胡逸民.肿瘤放射物理学.北京:原子能出版社,2003:8.
[28] 陈大朝,陈龙华,金吴东,等.三维适形放疗后放射性肝损伤的MRI表现.南方医科大学学报,2007,27(2):181-187.
[29] Onaya H, Itai Y, Ahmadi T, et al. Recurrent hepatocellular carcinoma versus radiation-induced hepatic injury.:differential diagnosis with MR imaging. Magn Reson Imaging, 2001, 19(1):41-46.
相似文献/References:
[1]包明月,刘玉龙.应用间充质干细胞治疗急性辐射损伤的研究现状与进展[J].国际放射医学核医学杂志,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
Bao Mingyue,Liu Yulong.Recent advances in the application of mesenchymal stem cells for treatment of acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
[2]贺欣,储小飞,罗丹,等.穿心莲药物对辐射损伤效应影响的初步研究[J].国际放射医学核医学杂志,2015,39(5):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
he xin,chu xiaofei,luo dan,et al.exploration of andrographolide effects on radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
[3]路璐,张俊伶,李德冠,等.6 gy 137cs γ射线照射对小鼠造血功能损伤的动态观察研究[J].国际放射医学核医学杂志,2015,39(5):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
lu lu*,zhang junling,li deguan,et al.effects of 6 gy 137cs γ-irradiattion on the hematopoietic system of mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
[4]刘惠惠,李险峰.放射性心脏损伤诊断和防治的临床研究进展[J].国际放射医学核医学杂志,2016,40(5):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
Liu Huihui,Li Xianfeng.Clinical research progress in diagnosis,prevention and treatment of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
[5]张倩如,李海涛,田红旗.小分子辐射防护药物的研究进展[J].国际放射医学核医学杂志,2016,40(5):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
Zhang Qianru,Li Haitao,Tian Hongqi.Small molecule compounds against radiation:research advances[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
[6]王浩,沈秀,靳瑾,等.“四物汤”对辐射危害的辅助保护作用研究[J].国际放射医学核医学杂志,2015,39(2):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
Wang Hao,Shen Xiu,Jin Jin,et al.Protective activity of Siwu Decoction against radiation hazards[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
[7]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[8]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[9]李德冠,路璐,吴红英,等.G-CSF联合SB203580对4Gy照射小鼠免疫系统的作用[J].国际放射医学核医学杂志,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
Li Deguan,Lu Lu,Wu Hongying,et al.The effects of G-CSF combined with SB203580 on the immune system of mice received 4 Gy total body irradiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
[10]张洪明,李险峰.放射性心脏损伤动物模型的研究进展[J].国际放射医学核医学杂志,2014,38(6):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
Zhang Hong-ming,Li Xian-feng.Progress in animal model of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
[11]赵水喜,郑静晨.放射治疗相关肝损伤的CT影像及其影响因素[J].国际放射医学核医学杂志,2006,30(6):372.
ZHAO Shui-xi,ZHENG Jing-chen.CT appearance and risk factors of hepatic injury related to radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):372.